Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 8, 2026, 8:02 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 433–456 of 1,484 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Standard Scheduling Clear all

Conditions: Obstructive Sleep Apnea
Interventions: HFNC, Low flow oxygen by nasal cannula; Other
Lead sponsor: Children's Hospital Medical Center, Cincinnati; Other
Eligibility: 1 Day to 12 Months
Enrollment: 9 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2021
U.S. locations: 2
States / cities: Kansas City, Kansas • Cincinnati, Ohio

Conditions: Smoking, Lung Neoplasms
Interventions: Integrated Fitness Assessment, Psychosocial Assessment and Care, Quality-of-Life Assessment; Other · Procedure
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Pediatric Solid Tumors, Rhabdomyosarcoma, Ewing Sarcoma, Osteosarcoma, Hodgkin Lymphoma, Bone Tumor, Soft Tissue Sarcoma
Interventions: Proton Therapy (Adaptive); Radiation
Lead sponsor: St. Jude Children's Research Hospital; Other
Eligibility: Not listed
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2031
U.S. locations: 1
States / cities: Memphis, Tennessee

Conditions: Human Papilloma Virus
Interventions: Swab kit (COBAS HPV 4800 Assay -Evalyn brush), Clinician-collection of cervical sample for HPV testing; Diagnostic Test
Lead sponsor: Mayo Clinic; Other
Eligibility: 25 Years to 65 Years · Female only
Enrollment: 222 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Defibrillators, Implantable, Tachycardia, Ventricular
Interventions: Ablation, Amiodarone; Procedure · Drug
Lead sponsor: Population Health Research Institute; Other
Eligibility: 19 Years to 84 Years
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2012
U.S. locations: 5
States / cities: Chicago, Illinois • Rochester, Minnesota • Philadelphia, Pennsylvania + 2 more

Conditions: Sexually Transmitted Diseases, Reproductive Behavior
Interventions: SexHealth; Behavioral
Lead sponsor: Children's Mercy Hospital Kansas City; Other
Eligibility: 14 Years to 19 Years
Enrollment: 91 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: Kansas City, Missouri

Conditions: Postsurgical Pain Management, Postsurgical Pain, Chronic, Opioid Use After Surgery
Interventions: TPS-Select, Pharmacologic Pain Management, Interventional Pain Procedures, Psychological Management and Pain Education, Physical Therapy; Device · Drug · Procedure + 1 more
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 474 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Huntington Disease
Interventions: Protocol Intervention Group; Other
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 21 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2023
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Inactivity, Physical, Sedentary Behavior
Interventions: COT-Based Intervention; Behavioral
Lead sponsor: University of California, San Diego; Other
Eligibility: 25 Years to 80 Years
Enrollment: 386 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: San Diego, California

Conditions: Heart Transplant Failure and Rejection
Interventions: The Prospera™ Test; Diagnostic Test
Lead sponsor: Natera, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 250 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 16
States / cities: Los Angeles, California • San Diego, California • Aurora, Colorado + 13 more

Conditions: Liver Transplant Surgery
Interventions: Cryoprecipitate Intercept Fibrinogen Complex (IFC), Cryoprecipitate Antihemophilic Factor (AHF); Biological
Lead sponsor: Ezeldeen Abuelkasem; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 3
States / cities: Cincinnati, Ohio • Pittsburgh, Pennsylvania

Conditions: Obstructive Sleep Apnea, Down Syndrome
Interventions: Sleep study; Other
Lead sponsor: Oregon Health and Science University; Other
Eligibility: 2 Years to 17 Years
Enrollment: 81 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2027
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Atherosclerosis
Interventions: Research Ultrasound Exam; Device
Lead sponsor: D. Geoffrey Vince; Other
Eligibility: 40 Years and older
Enrollment: 150 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2020
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Diabetes Mellitus, Type 2
Interventions: Pharmacy Managed Diabetes Clinic (PMDC), Standard of Care (SOC); Behavioral · Other
Lead sponsor: Corewell Health East; Other
Eligibility: 18 Years to 75 Years
Enrollment: 86 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 4
States / cities: Berkley, Michigan • Royal Oak, Michigan • Southfield, Michigan + 1 more

Conditions: HER2-negative Breast Cancer, Hormone-receptor-positive Breast Cancer, Metastatic Breast Cancer, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, HER2 Negative Breast Carcinoma, Hormone Receptor Positive Breast Carcinoma, Metastatic Breast Carcinoma
Interventions: Biospecimen Collection; Procedure
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older · Female only
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2031
U.S. locations: 1
States / cities: Jacksonville, Florida

Conditions: Glaucoma
Interventions: App; Other
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Proliferative Diabetic Retinopathy, Diabetic Retinopathy, Diabetes
Interventions: PDS Implant filled with 100 mg/mL Ranibizumab, Ranibizumab; Device · Drug
Lead sponsor: Southeast Retina Center, Georgia; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Augusta, Georgia

Conditions: Class I Obesity, Pediatric Obesity
Interventions: Virtual Housecalls; Behavioral
Lead sponsor: Virginia Commonwealth University; Other
Eligibility: 12 Years to 15 Years
Enrollment: 500 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: Henrico, Virginia

Conditions: Carcinoma, Non-Small-Cell Lung
Interventions: Erlotinib, Platinum-based chemotherapy; Drug
Lead sponsor: New Mexico Cancer Research Alliance; Other
Eligibility: 18 Years to 80 Years
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2012
U.S. locations: 5
States / cities: Albuquerque, New Mexico • Santa Fe, New Mexico

Conditions: Preterm Birth
Interventions: Targeted Nurse Home Visits, Conventional prenatal/postpartum care; Behavioral · Other
Lead sponsor: Vanderbilt University; Other
Eligibility: 18 Years to 40 Years · Female only
Enrollment: 236 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2012
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Multiple Myeloma
Interventions: BCMA CART + huCART19, CART BCMA or CART BCMA + huCART19, Single-dose infusion of CART BCMA or CART BCMA + huCART19; Biological
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2036
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Emergency Department Visit
Interventions: Intensive Care Coordination; Other
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 18 Years to 64 Years
Enrollment: 3,405 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2024
U.S. locations: 4
States / cities: Appleton, Wisconsin • Glendale, Wisconsin • Milwaukee, Wisconsin + 1 more

Conditions: Hepatitis C
Interventions: Data-assisted Case Navigation, Standard of Care; Behavioral
Lead sponsor: National Opinion Research Center; Other
Eligibility: 18 Years and older
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Immune Thrombocytopenic Purpura
Interventions: Dexamethasone USP Micronized, Prednisone; Drug
Lead sponsor: Carelon Research; Other
Eligibility: 15 Years and older
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2013
U.S. locations: 18
States / cities: New Orleans, Louisiana • Baltimore, Maryland • Boston, Massachusetts + 10 more

Search by objective public record fields.

Comparison of High Flow Nasal Cannula Therapy to Nasal Oxygen as a Treatment for Obstructive Sleep Apnea in Infants

Patient Function/Fitness and Psychosocial Health in Improving Health-Related Quality of Life in Patients With Stage I-IV Non-Small Cell Lung Cancer

Integration of Adaptive Proton Therapy in Pediatric Solid Tumors and Hodgkin's Lymphoma

Patient Self-sampling of HPV to Screen for Cervical Cancer

Catheter Ablation Versus Amiodarone for Shock Prophylaxis in Defibrillator Patients With Ventricular Tachycardia

Enhanced SexHealth Intervention to Improve Adolescent Outcomes

An Artificial Intelligence Driven Approach to Optimize Patient Selection for a Transitional Pain Service

Assessing Efficacy of Neuropsychiatric Assessment and Treatment Protocols in Huntington's Disease Patients

The YourMove Study: Optimizing Individualized and Adaptive mHealth Interventions Via Control Systems Engineering Methods

A Comparative Effectiveness Study in Heart Transplant Patients of Rejection Surveillance With Cell-free DNA Versus Endomyocardial Biopsy

Fibrinogen in Liver Transplant Subjects

Validation of Sleep Questionnaires in the Down Syndrome Population

Pilot Study of Ultrasonic Determined Carotid Plaque Composition

Impact of Pharmacy Clinic on Diabetes Management

DiviTum®TKa: A Biomarker Assay for Efficacy in HR+ Breast Cancer Patients

An App-based Instructional Platform to Improve Eye Drop Recall

Continuous Delivery of Ranibizumab Via the Port Delivery System for Proliferative Diabetic Retinopathy-related Vitreous Hemorrhage With Pars Plana Vitrectomy and Limited PRP.

Virtual Housecalls: Redesigning Pediatric Primary Care Adolescent Obesity Treatment

Erlotinib and Standard Platinum-Based Chemotherapy for Newly Diagnosed, Advanced Non-Small Cell Carcinoma of the Lung

Tennessee Connections for Better Birth Outcomes

Up-front CART-BCMA With or Without huCART19 in High-risk Multiple Myeloma

Wisconsin Evaluation of Emergency Department Care Coordination

Registry-based HCV Care Cascade Navigation at Atlanta's Grady Memorial Hospital

Initial Treatment of Patients With Immune Thrombocytopenic Purpura